Penumbra, Inc. Cash Flow Statement
PEN / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
Penumbra, Inc. generated $239M in operating cash flow and $175M in free cash flow in FY2025. Free cash flow margin was 12.5% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $177.7M | $14.0M | $91.0M | -$15.7M | $48.5M | -$15.7M | $4.7M | $14.8M | $2.4M | $14.8M | $2.4M | $2.2M | $4.1M |
| Depreciation & Amortization | $17.5M | $23.7M | $27.3M | $12.9M | $8.1M | $12.9M | $3.8M | $2.3M | $1.8M | $2.3M | $1.8M | $751.0K | $677.0K |
| Operating Cash Flow | $238.7M | $168.5M | $97.3M | -$33.2M | $26.7M | -$33.2M | $12.7M | -$12.8M | -$20.7M | -$12.8M | -$20.7M | -$6.4M | -$3.4M |
| Capital Expenditures | $63.7M | $21.2M | $15.2M | $24.8M | $22.1M | $24.8M | $12.5M | $13.6M | $5.5M | $13.6M | $5.5M | $3.9M | $798.0K |
| Free Cash Flow | $174.9M | $147.3M | $82.1M | -$58.0M | $4.5M | -$58.0M | $159.0K | -$26.4M | -$26.2M | -$26.4M | -$26.2M | -$10.3M | -$4.2M |
| Share Buybacks | $0 | $100.4M | $0 | - | - | - | - | - | - | - | - | - | - |
| FCF Margin | 12.5% | 12.3% | 7.8% | -10.3% | 0.8% | -10.3% | 0.1% | -10.0% | -14.1% | -10.0% | -14.1% | -8.2% | -4.7% |